| Financial Year |
March 31 2023 |
| Monetary Funds |
516,731,185.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
125,336,798.31 |
| Advances to Suppliers |
13,905,988.10 |
| Other Receivables |
11,369,189.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,478,680.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,891,142.92 |
| Total Current Assets |
766,712,984.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
131,259,009.99 |
| Investment Properties |
8,804,761.71 |
| Fixed Assetes |
336,949,282.49 |
| Under-construction Projects |
1,534,626.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,697,046.72 |
| Deferred Income Tax Assets |
176,278,214.30 |
| Other Non-Current Assets |
5,137,985.20 |
| Sub-Total of Non-Current Assets |
750,212,376.88 |
| Total Assets |
1,516,925,361.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
59,582,858.71 |
| Accounts Received In Advance |
976,067.75 |
| Employee Compensation Payable |
3,582,338.94 |
| Taxes Payable |
7,015,476.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
141,505,895.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,134,514.16 |
| Other Current Liabilities |
295,755.99 |
| Sub-Total of Current Liabilities |
336,571,503.46 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,873,322.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
123,611,498.89 |
| Total Liabilities |
460,183,002.35 |
| Paid-In Capital(Or Share Stock) |
397,706,400.00 |
| Capital Surplus |
253,650,492.34 |
| Surplus Reserve |
159,387,468.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
202,193,256.37 |
| Minority Stockholder's Interest |
43,804,741.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,012,937,617.00 |
| Owner's Equity（Stockholder's Equity） |
1,056,742,358.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,516,925,361.18 |
